SmithKline Beecham Pharmaceuticals’ cysteinyl leukotriene receptor antagonists: Pranlukast (SB 205312; Ono-1078; Onon), Pobilukast (SK&F 104353) and SK&F 106203
Author:
Hay Douglas W. P.
Publisher
Birkhäuser Basel
Reference105 articles.
1. Obata T, Okada Y, Motoishi M, Nakagawa N, Terawaki T, Aishita H (1992) In vitro antagonism of ONO-1078, a newly developed anti-asthma agent, against peptide leukotrienes in isolated guinea pig tissues. Jap J Pharmacol 60: 227–237 2. Augstein J, Farmer JB, Lee TB, Sheard P, Tattersall ML (1973) Selective inhibition of slow reacting substance of anaphylaxis. Nature 245: 215–216 3. Nabe T, Kohno S, Tanpo T, Saeki Y, Yamamura H, Horiba M, Ohata K (1994) Inhibitory effect of ONO-1078 on specific binding of peptide leukotrienes to human lung crude membrane. Prostaglandins Leukot Essent Fatty Acids 51: 163–171 4. Yamaguchi T, Kohrogi H, Honda I, Kawano O, Sugimoto M, Araki S, Ando M (1992) A novel leukotriene antagonist, ONO-1078, inhibits and reverses human bronchial contraction induced by leukotrienes C4 and D4 and antigen in vitro. Am Rev Respir Dis 146: 923–929 5. Fujiwara H, Kurihara N, Ohta, Hirata K, Matsushita H, Kanazawa H, Takeda T (1993) Effect of a new leukotriene receptor antagonist, ONO-1078, on human bronchial smooth muscle in vitro. Prostaglandins Leukot Essent Fatty Acids 48: 241–246
|
|